Literature DB >> 14082744

FOLIC ACID ANTAGONIST. EFFECTS ON THE CELL AND THE PATIENT. COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH.

N I BERLIN, D RALL, J A MEAD, E J FREIREICH, E VANSCOTT, R HERTZ, M B LIPSETT.   

Abstract

Entities:  

Keywords:  BIOCHEMISTRY; BONE MARROW; CHILD; CHORIOCARCINOMA; EPITHELIUM; FOLIC ACID ANTAGONISTS; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOCYTIC; METABOLISM; PATHOLOGY; PHARMACOLOGY; TOXICOLOGIC REPORT; TROPHOBLASTIC TUMOR

Mesh：

Substances：

Year:  1963        PMID： 14082744     DOI： 10.7326/0003-4819-59-6-931

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  12 in total

1.  Brain damage after intrathecal methotrexate.

Authors:  B Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-08       Impact factor: 10.154

Review 2.  Antineoplastic and immunosuppressive drugs. I. Biochemical and clinical pharmacological considerations.

Authors:  A H Chalmers; L A Burgoyne; A W Murray
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 3.  [Basic questions of external psoriasis therapy].

Authors:  H Ippen
Journal:  Arch Klin Exp Dermatol       Date:  1966

4.  Methotrexate therapy in polymyositis.

Authors:  F C Arnett; J C Whelton; T M Zizic; M B Stevens
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

5.  Megaloblastic anaemia during methotrexate treatment of psoriasis.

Authors:  P Borrie; P A Clark
Journal:  Br Med J       Date:  1966-05-28

Review 6.  The practical use of methotrexate in psoriasis.

Authors:  J P Tung; H I Maibach
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

7.  Intermittent cyclophosphamide treatment of autoimmune thombocytopenia.

Authors:  B Weinerman; I Maxwell; W Hryniuk
Journal:  Can Med Assoc J       Date:  1974-11-16       Impact factor: 8.262

8.  Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.

Authors:  S B Lanse; G L Arnold; J D Gowans; M M Kaplan
Journal:  Dig Dis Sci       Date:  1985-02       Impact factor: 3.199

Review 9.  Determination of Folic Acid Using Biosensors-A Short Review of Recent Progress.

Authors:  Alessio Di Tinno; Rocco Cancelliere; Laura Micheli
Journal:  Sensors (Basel)       Date:  2021-05-12       Impact factor: 3.576

10.  Anabolic steroids and bone marrow toxicity during therapy with methotrexate.

Authors:  R G Rawbone; K D Bagshawe
Journal:  Br J Cancer       Date:  1972-10       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.